• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Analysis of anti-cancer effect for the chemokine SDF-1 and the receptor CXCR4 in gastrointestinal cancer

Research Project

Project/Area Number 11671251
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

KENJI Shibuta  Medical Institute of Bioregulation Kyushu Univ.Research Associate, 生体防御医学研究所, 助手 (70253531)

Co-Investigator(Kenkyū-buntansha) SADANAGA Noriaki  Medical Institute of Bioregulation Kyushu Univ.Research Associate, 生体防御医学研究所, 助手 (20304826)
MORI Masaki  Medical Institute of Bioregulation Kyushu Univ.Professor, 生体防御医学研究所, 教授 (70190999)
Project Period (FY) 1999 – 2000
Keywordsgastrointestinal cancer / hepatoma / CXC chemokine / SDF-1 / CXCR4 / RT-PCR
Research Abstract

We have recently demonstrated on Northern blots analysis and reverse transcription-polymerase chain reaction (RT-PCR) that expression of the a-chemokine hIRH/SDF-1a mRNA was reduced in human hepatocellular carcinoma, digestive tract cancers such as esophageal cancer, gastric cancer and colon cancer, human malignant cell lines and colonic premalignant polyp although its expression is common in human normal tissues. Furthermore, there are no more than our two reports on the mRNA status of a-chemokine receptor CXCR4, whose ligand is hIRH/SDF-1a, in human cancers. The present study was designed to analyze the expression of CXCR4 mRNA by RT-PCR and to investigate the distribution of SDF-1a/CXCR4 proteins expression in hepatocellular carcinoma, adjacent normal liver tissue and human malignant cell lines by the immunochemical staining. Although CXCR4 mRNA was expressed widely on human almost normal organs and maligmant cell lines, the expression in the majority of hepatoma was reduced compared with that in adjacent non-cancer tissue. There was a significant correlation in the intensity of mRNA expression between CXCR4 and its ligand hIRH/SDF-1. Furthermore, the immunochemical staining in vivo and in vitro showed that CXCR4 was expressed on varing intracellular molecules such as the nuclear surface, the intranucleus and the cytoplasm. Particularly, CXCR4 expression in cytoplasm was definitely limited to the hepatocells around the central vein, and is constitutively consistent with that of SDF-1a. Based on these facts, the CXCR4/SDF-1 interaction possibly plays an important role of liver carcinogenesis in vivo.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Shibuta k. et al.: "L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer."Jpn.J.Cancer Res.. 91. 199-203 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shibuta K. et al.: "Genetic polymorphism of N-acetyltransferase2 in the patients with esophageal cancer.Am.J.Gastroentol."Am.J.Gastroentol.. (in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mitra P,Shibuta K. et al: "CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver."Int.J.Oncol.. 14. 917-925 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Begum NA,Shibuta K. et al.: "Reduced expression of the CXCR4 receptor mRNA in hepatocellular carcinoma and lack of inducibility of its ligand -chemokine hIRH/SDF α/PBSF in vitro."Int.J.Oncol.. 14. 927-934 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shibuta K. et al.: "Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer."Br.J.Surg.. 85. 681-684 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shibuta K. et al.: "Reduced expression of the CXC chemokine hIRH/SDF-1a mRNA in hepatoma and digestive tract cancer."Int.J.Cancer. 73. 656-662 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shibuta K.et al.: "L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer."Jpn.J.Cancer Res.. 91. 199-203 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shibuta K.et al.: "Genetic polymorphism of N-acetyltransferase2 in the patients with esophageal cancer. Am.J.Gastroentol."Am.J.Gastroentol. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mitra P, Shibuta K.et al: "CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver."Int.J.Oncol.. 14. 917-925 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Begum NA, Shibuta K.et al.: "Reduced expression of the CXCR4 receptor mRNA in hepatocellular carcinoma and lack of inducibility of its ligand -chemokine hIRH/SDFα/PBSF in vitro."Int.J.Oncol.. 14. 927-934 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shibuta K.et al.: "Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer."Br.J.Surg. 85. 681-684 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shibuta K.et al.: "Reduced expression of the CXC chemokine hIRH/SDF-1a mRNA in hepatoma and digestive tract cancer."Int.J.Cancer. 73. 656-662 (1997)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi